Sergio Baranzini
Cited by
Cited by
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas, SE Baranzini, D Mitchell, CCA Bernard, SR Rittling, ...
Science 294 (5547), 1731-1735, 2001
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ...
Nature genetics 41 (7), 776-782, 2009
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models
E Cekanaviciute, BB Yoo, TF Runia, JW Debelius, S Singh, CA Nelson, ...
Proceedings of the National Academy of Sciences 114 (40), 10713-10718, 2017
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice
K Berer, LA Gerdes, E Cekanaviciute, X Jia, L Xiao, Z Xia, C Liu, L Klotz, ...
Proceedings of the National Academy of Sciences 114 (40), 10719-10724, 2017
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome
DT Okuda, EM Mowry, A Beheshtian, E Waubant, SE Baranzini, ...
Neurology 72 (9), 800-805, 2009
Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS
SPJ Fancy, SE Baranzini, C Zhao, DI Yuk, KA Irvine, S Kaing, N Sanai, ...
Genes & development 23 (13), 1571-1585, 2009
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
MH Han, SI Hwang, DB Roy, DH Lundgren, JV Price, SS Ousman, ...
Nature 451 (7182), 1076-1081, 2008
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
SE Baranzini, J Wang, RA Gibson, N Galwey, Y Naegelin, F Barkhof, ...
Human molecular genetics 18 (4), 767-778, 2009
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis
SE Baranzini, J Mudge, JC Van Velkinburgh, P Khankhanian, ...
Nature 464 (7293), 1351-1356, 2010
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis
SE Baranzini, NW Galwey, J Wang, P Khankhanian, R Lindberg, ...
Human molecular genetics 18 (11), 2078-2090, 2009
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
DS Himmelstein, A Lizee, C Hessler, L Brueggeman, SL Chen, D Hadley, ...
Elife 6, e26726, 2017
The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
JR Oksenberg, SE Baranzini, S Sawcer, SL Hauser
Nature Reviews Genetics 9 (7), 516-526, 2008
Long‐term evolution of multiple sclerosis disability in the treatment era
University of California, San Francisco MS‐EPIC Team:, BAC Cree, ...
Annals of neurology 80 (4), 499-510, 2016
The genetics of multiple sclerosis: an up‐to‐date review
PA Gourraud, HF Harbo, SL Hauser, SE Baranzini
Immunological reviews 248 (1), 87-103, 2012
Class II HLA interactions modulate genetic risk for multiple sclerosis
Nature genetics 47 (10), 1107-1113, 2015
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
LF Barcellos, S Sawcer, PP Ramsay, SE Baranzini, G Thomson, F Briggs, ...
Human molecular genetics 15 (18), 2813-2824, 2006
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans
JR Oksenberg, LF Barcellos, BAC Cree, SE Baranzini, TL Bugawan, ...
The American Journal of Human Genetics 74 (1), 160-167, 2004
The system can't perform the operation now. Try again later.
Articles 1–20